カテゴリ： GlobalData, 企業調査, 香港

Lee’s Pharmaceutical Holdings Ltd (950)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Lee's Pharmaceutical Holdings Ltd (950) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C8030
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：78
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：香港
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Lee’s Pharmaceutical Holdings Ltd (Lee’s Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology, ophthalmology, dermatology, and gynecology. Its products are used for therapeutic indications that include cornea ulcer, reduction of bleeding, viral-infected venereal diseases, and other cardiovascular diseases. Lee’s Pharmaceutical offers pipeline products for cardiovascular, oncology related diseases; ophthalmology, dermatology, and ophthalmology are in different preclinical stages. The company works in partnership with other organizations for the development, and distribution rights for products across the US, Japan and Europe. It operates through its manufacturing facility located at Hefei City, China. Lee’s Pharmaceutical is headquartered in Hong Kong.

Lee’s Pharmaceutical Holdings Ltd (950) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Lee’s Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Lee’s Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Lee’s Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Lee’s Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Lee’s Pharmaceutical Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12
Lee’s Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Lee’s Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 16
Venture Financing 16
Tragara Pharma Raises USD13 Million in Series C Financing 16
Partnerships 18
Lee’s Pharma Enters into Agreement with Shenogen Pharma 18
Lee’s Pharma Enters into Agreement with Beijing Shenogen Pharma 19
ScinoPharm Enters into Agreement with CVie Therapeutics 20
INO Therapeutics Enters into Agreement with Lee’s Pharma for Inomax 21
ScinoPharm Enters Into Co-Development Agreement With Lee’s Pharma For Fondaparinux Sodium 22
ScinoPharm Announces Co-Development Agreement With Lee’s Pharma For Travoprost And Bimatoprost 23
Licensing Agreements 24
Lee’s Pharma Enters into Licensing Agreement with Alexza Pharma 24
Lee’s Pharma Enters into Licensing Agreement with GC Pharma 25
Lee’s Pharma Enters into Licensing Agreement with Noden Pharma 26
Lee’s Pharma Enters into Licensing Agreement with Windtree Therapeutics 27
Lee’s Pharma Enters into Licensing Agreement with Solasia Pharma 29
Lee’s Pharma Enters into Licensing Agreement with TOT Biopharm 30
Lee’s Pharma Enters into Licensing Agreement with Kato Pharma 31
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 32
Lee’s Pharma Enters into Licensing Agreement with Solasia Pharma for Sancuso 33
Lee’s Pharma Enters into Licensing Agreement with Tragara Pharma 34
China Cardiovascular Focus Enters into Licensing Agreement with Armetheon 35
Lee’s Pharma Enters into Licensing Agreement with BioQuiddity 36
Sorrento Therapeutics Enters into Licensing Agreement with Lee’s Pharma for Anti-PD-L1 Antibody 37
Abiogen Pharma Enters into Licensing Agreement with Lee’s Pharma for Thorens Cholecalciferol 38
Abiogen Pharma Enters into Licensing Agreement with Lee’s Pharma for Attila 39
Dyax Amends Licensing Agreement With CVie Therapeutics For Kalbitor 40
RegeneRx Biopharma Enters into Licensing Agreement with Lee’s Pharma for RGN-259, RGN-352 and RGN-137 41
CVie Therapeutics to Enter into Licensing Agreement with Sigma-Tau 43
CVie Therapeutics to Enter into Licensing Agreement with RostaQuo 45
CVie Therapeutics Enters into Licensing Agreement with Sigma-Tau Industrie 47
PLx Pharma Enters into Licensing Agreement with Lee’s Pharma for Cardiovascular Product 48
Dilafor Enters Into Licensing Agreement With Lee’s Pharma 49
Lee’s Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 50
Lee’s Pharma HK Enters into Licensing Agreement with Sigma-Tau Industrie Farmaceutiche Riunite 51
Equity Offering 52
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 52
CVie Therapeutics Raises USD10 Million in Private Placement of Shares 54
Asset Transactions 55
Lee’s Pharma to Sell Products to China Oncology Focus for USD13.6 Million 55
Zhaoke Pharma to Sell Products to China Oncology Focus for USD0.9 Million 56
Acquisition 57
Lee’s Pharmaceutical Acquires 65% Stake in China Oncology Focus 57
Lee’s Pharmaceutical Holdings Ltd – Key Competitors 58
Lee’s Pharmaceutical Holdings Ltd – Key Employees 59
Lee’s Pharmaceutical Holdings Ltd – Locations And Subsidiaries 60
Head Office 60
Other Locations & Subsidiaries 60
Affiliate 60
Recent Developments 62
Financial Announcements 62
Aug 30, 2018: Lee’s Pharmaceutical Holdings: Interim results for the six months ended 30 June 2018 62
May 24, 2018: Lee’s Pharmaceutical Holdings: First Quarterly Results For The Three Months Ended 31 March 2018 65
Mar 22, 2018: Lee’s Pharmaceutical Holdings:Announcement Of Annual Results For The Year Ended 31 December 2017 67
Aug 24, 2017: Lee’s Pharmaceutical Holdings: Interim Results For The Six Months Ended 30 June 2017 72
Corporate Communications 74
Dec 29, 2017: Lee’s Pharmaceutical Holdings: Resignation and Appointment of Non-Executive Director 74
Product News 76
03/09/2017: China FDA has Approved Zingo for Pediatric Use Needle-free Local Analgesia as Priority Review for Clinical Trial 76
Other Significant Developments 77
May 28, 2018: Lee’s Pharmaceutical: Change Of Address Of Head Office And Principal Place Of Business In Hong Kong 77
Appendix 78
Methodology 78
About GlobalData 78
Contact Us 78
Disclaimer 78

List of Tables
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Lee's Pharmaceutical Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 10
Lee's Pharmaceutical Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Tragara Pharma Raises USD13 Million in Series C Financing 16
Lee's Pharma Enters into Agreement with Shenogen Pharma 18
Lee’s Pharma Enters into Agreement with Beijing Shenogen Pharma 19
ScinoPharm Enters into Agreement with CVie Therapeutics 20
INO Therapeutics Enters into Agreement with Lee's Pharma for Inomax 21
ScinoPharm Enters Into Co-Development Agreement With Lee’s Pharma For Fondaparinux Sodium 22
ScinoPharm Announces Co-Development Agreement With Lee’s Pharma For Travoprost And Bimatoprost 23
Lee’s Pharma Enters into Licensing Agreement with Alexza Pharma 24
Lee's Pharma Enters into Licensing Agreement with GC Pharma 25
Lee's Pharma Enters into Licensing Agreement with Noden Pharma 26
Lee’s Pharma Enters into Licensing Agreement with Windtree Therapeutics 27
Lee’s Pharma Enters into Licensing Agreement with Solasia Pharma 29
Lee's Pharma Enters into Licensing Agreement with TOT Biopharm 30
Lee's Pharma Enters into Licensing Agreement with Kato Pharma 31
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 32
Lee's Pharma Enters into Licensing Agreement with Solasia Pharma for Sancuso 33
Lee's Pharma Enters into Licensing Agreement with Tragara Pharma 34
China Cardiovascular Focus Enters into Licensing Agreement with Armetheon 35
Lee’s Pharma Enters into Licensing Agreement with BioQuiddity 36
Sorrento Therapeutics Enters into Licensing Agreement with Lee's Pharma for Anti-PD-L1 Antibody 37
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Thorens Cholecalciferol 38
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Attila 39
Dyax Amends Licensing Agreement With CVie Therapeutics For Kalbitor 40
RegeneRx Biopharma Enters into Licensing Agreement with Lee's Pharma for RGN-259, RGN-352 and RGN-137 41
CVie Therapeutics to Enter into Licensing Agreement with Sigma-Tau 43
CVie Therapeutics to Enter into Licensing Agreement with RostaQuo 45
CVie Therapeutics Enters into Licensing Agreement with Sigma-Tau Industrie 47
PLx Pharma Enters into Licensing Agreement with Lee's Pharma for Cardiovascular Product 48
Dilafor Enters Into Licensing Agreement With Lee’s Pharma 49
Lee's Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 50
Lee’s Pharma HK Enters into Licensing Agreement with Sigma-Tau Industrie Farmaceutiche Riunite 51
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 52
CVie Therapeutics Raises USD10 Million in Private Placement of Shares 54
Lee's Pharma to Sell Products to China Oncology Focus for USD13.6 Million 55
Zhaoke Pharma to Sell Products to China Oncology Focus for USD0.9 Million 56
Lee’s Pharmaceutical Acquires 65% Stake in China Oncology Focus 57
Lee's Pharmaceutical Holdings Ltd, Key Competitors 58
Lee's Pharmaceutical Holdings Ltd, Key Employees 59
Lee's Pharmaceutical Holdings Ltd, Subsidiaries 60
Lee's Pharmaceutical Holdings Ltd, Affiliate 60

List of Figures
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Lee's Pharmaceutical Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12

★海外企業調査レポート[Lee’s Pharmaceutical Holdings Ltd (950)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Symrise AG (SY1)：製薬・医療：M&Aディール及び事業提携情報
    Summary Symrise AG (Symrise) offers flavors and fragrances. The company develops, produces and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions for the cosmetics industry. It also provides biofunctional and bioactive ingredients an …
  • Lockheed Martin Corporation：企業のM&A・事業提携・投資動向
    Lockheed Martin Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lockheed Martin Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Mediclinic International Plc (MDC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Mediclinic International Plc (Mediclinic), formerly Al Noor Hospitals Group Plc is a healthcare service provider. The center offers services such as specialist-orientated, acute-care and multi disciplinary healthcare services. It also provides clinical services such as pre hospital emergency …
  • French National Institute of Health and Medical Research-医療機器分野：企業M&A・提携分析
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …
  • NorthWestern Corporation (NWE)-石油・ガス分野：企業M&A・提携分析
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an integrated electric utility which generates, transmits, and distributes electricity and distributes natural gas in South Dakota, Nebraska and Montana. It produces energy from wind, hydro, natural gas, and coal-fired sourc …
  • Innopharmax Inc (4172)：製薬・医療：M&Aディール及び事業提携情報
    Summary Innopharmax Inc (InnoPharmax), a subsidiary of Synmosa Biopharma Corp is a pharmaceutical company that develops and commercializes products for the treatment of oncology and specialty. The company provides anti-infection agents, oncology agents, contrast agents, immunological agents and drug …
  • Worthington Industries Inc：企業のM&A・事業提携・投資動向
    Worthington Industries Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Worthington Industries Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • The Shipping Corporation of India Ltd (SCI)：企業の財務・戦略的SWOT分析
    The Shipping Corporation of India Ltd (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Vivimed Labs Ltd (VIVIMEDLAB)：企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Jyoti Structures Ltd (JYOTISTRUC)：企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • ALPCO Diagnostics：医療機器：M&Aディール及び事業提携情報
    Summary ALPCO Diagnostics (ALPCO) is a life science company that imports and distributes immunoassay based products. The company offers immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It provides food additives, …
  • Swietelsky Baugesellschaft mbH：企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Epax Norway AS：企業の戦略・SWOT・財務情報
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • SKF AB：企業の戦略・SWOT・財務情報
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Saint-Gobain Weber GmbH：企業の戦略・SWOT・財務分析
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Minerva Surgical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Minerva Surgical Inc (Minerva) is a medical technology company that develops devices in the areas of women's healthcare. The company develops surgical devices and delivers products for the treatment of abnormal uterine bleeding. It provides various medical device based therapies to the patie …
  • Helius Medical Technologies Inc (HSM)：製品パイプライン分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that offers neurological wellness solutions. The company offers development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It offers development of technolog …
  • Circassia Pharmaceuticals Plc (CIR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Optiscan Imaging Limited (OIL)：製品パイプライン分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆